Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of TollB-001 in moderate-to-severe active rheumatoid arthritis
CTR20253314Phase 2Active
- Sponsor
- 北京拓领博泰生物科技
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tollb-001 in rheumatoid arthritis (RA), sponsored by 北京拓领博泰生物科技. Started Sep 2025; status: active.
02
Drugs
tollb-001
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20253314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253314.